ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The T-cell-specific cell-surface receptors CD28 and CTLA-4 are important regulators of the immune system. CD28 potently enhances those T-cell functions that are essential for an effective antigen-specific immune response, and the homologous CTLA-4 counterbalances the CD28-mediated signals and thus prevents an otherwise fatal overstimulation of the lymphoid system. Here we report the identification of a third member of this family of molecules, inducible co-stimulator (ICOS), which is a homodimeric protein of relative molecular mass 55,000-60,000 (M(r) 55K-60K). Matching CD28 in potency, ICOS enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, upregulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B cells. Unlike the constitutively expressed CD28, ICOS has to be de novo induced on the T-cell surface, does not upregulate the production of interleukin-2, but superinduces the synthesis of interleukin-10, a B-cell-differentiation factor. In vivo, ICOS is highly expressed on tonsillar T cells, which are closely associated with B cells in the apical light zone of germinal centres, the site of terminal B-cell maturation. Our results indicate that ICOS is another major regulator of the adaptive immune system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune co-stimulator (ICOS) is a co-stimulatory molecule expressed on T cells, which enhances function and expansion of CD8+ T cells and Tregs (Fu et al., 2011; Hutloff et al., 1999; Liakou et al., 2008).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Hutloff et al., 1999
Citations
Cites
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
A new member of the immunoglobulin superfamily—CTLA-4
Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., & Golstein, P. (1987) · Nature · doi:10.1038/328267a0 · Cited by 1,306
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,257
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90061-b · Cited by 1,239 · cited 1×
“Protein material from five gels was pooled, in situ -digested with trypsi”
Method
Cited by
Items 501–600 of 1,001
Tan, A. H., Goh, S. Y.-P., Wong, S. C., & Lam, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707693200 · Cited by 53
Okamoto, N., Tezuka, K., Kato, M., Abe, R., & Tsuji, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.065 · Cited by 53
Cellular and molecular mechanisms of memory T-cell survival
Tanel, A., Fonseca, S. G., Yassine‐Diab, B., Bordi, R., Zeidan, J., Shi, Y., Benne, C., & Sékaly, R. (2009) · Expert Review of Vaccines · doi:10.1586/14760584.8.3.299 · Cited by 56
Common Variable Immunodeficiency and Gastric Malignancies
Leone, P., Vacca, A., Dammacco, F., & Racanelli, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020451 · Cited by 55
Kawamoto, M., Harigai, M., Hara, M., Kawaguchi, Y., Tezuka, K., Tanaka, M., Sugiura, T., Katsumata, Y., Fukasawa, C., Ichida, H., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1928 · Cited by 52
Current concepts of non-coding RNA regulation of immune checkpoints in cancer
Smolle, M. A., Prinz, F., Calin, G. A., & Pichler, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.007 · Cited by 52
T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses
Skånland, S. S., Moltu, K., Berge, T., Aandahl, E. M., & Taskén, K. (2014) · Biochemical Journal · doi:10.1042/bj20140040 · Cited by 62
Kean, L. S., Turka, L. A., & Blazar, B. R. (2017) · Immunological Reviews · doi:10.1111/imr.12523 · Cited by 52
Targeting T cell costimulation in autoimmune disease
Racke, M. K., & Stuart, R. W. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.3.275 · Cited by 56
ICOS+ Th cells produce distinct cytokines in different mucosal immune responses
Bonhagen, K., Liesenfeld, O., Stadecker, M. J., Hutloff, A., Erb, K. J., Coyle, A. J., Lipp, M., Kroczek, R. A., & Kamradt, T. (2003) · European Journal of Immunology · doi:10.1002/immu.200310013 · Cited by 62
Self-citationFischbein, M. P., Ardehali, A. A., Yun, J. J., Schoenberger, S. P., Laks, H., Irie, Y., Dempsey, P. W., Cheng, G., Fishbein, M. C., & Bonavida, B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7316 · Cited by 53
Inducible T‐cell co‐stimulator: Signaling mechanisms in T follicular helper cells and beyond
Panneton, V., Chang, J., Witalis, M., Li, J., & Suh, W. (2019) · Immunological Reviews · doi:10.1111/imr.12771 · Cited by 59
“This may allow cis‐ (1) or trans‐interaction (2) that is known to increase Bcl2 and pSTAT5 levels through ill‐defined mechanisms.”
BackgroundThe Antigen Presenting Potential of CD21low B Cells
Reincke, M., Payne, K. J., Harder, I., Strohmeier, V., Voll, R. E., Warnatz, K., & Keller, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.535784 · Cited by 52
Marinova, E., Han, S., & Zheng, B. Q. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5010 · Cited by 52
Trophoblast Immune Receptors in Maternal-Fetal Tolerance
Riley, J. K. (2008) · Immunological Investigations · doi:10.1080/08820130802206066 · Cited by 55
Common variable immunodeficiency in children
Glocker, E. O., Ehl, S. R., & Grimbacher, B. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282f1ddd5 · Cited by 50
Richter, G. H. S., Hayden-Ledbetter, M. S., Irgang, M., Ledbetter, J. A., Westermann, J., Körner, I. J., Daemen, K., Clark, E. A., Aicher, A., & Pezzutto, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108509200 · Cited by 50
Hubbard, V. M., Eng, J. M., Ramirez‐Montagut, T., Tjoe, K. H., Muriglan, S. J., Kochman, A. A., Terwey, T. H., Willis, L. M., Schiro, R., Heller, G., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0410 · Cited by 50
Changes in Follicular Helper T Cells in Idiopathic Thrombocytopenic Purpura Patients
Xie, J., Cui, D., Liu, Y., Jin, J., Tong, H., Wang, L., Ruan, G., Lu, Y., & Yuan, H. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10178 · Cited by 50
Susceptibility Genes in Thyroid Autoimmunity
Ban, Y., & Tomer, Y. (2004) · Journal of Immunology Research · doi:10.1080/17402520400008897 · Cited by 50
Guo, L., Li, X., Funeshima, N., Fujino, M., Nagata, Y., Kimura, H., Amemiya, H., Enosawa, S., Tsuji, T., Harihara, Y., et al. (2002) · Transplantation · doi:10.1097/00007890-200204150-00003 · Cited by 50
Broeren, C. P. M., Gray, G. S., Carreno, B. M., & June, C. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6908 · Cited by 55
The B7/CD28/CTLA4 T-Cell Activation Pathway: Implications for Inflammatory Lung Disease
Green, J. M. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.3.f179 · Cited by 53
Prevot, N., Briet, C., Lassmann, H., Tardivel, I., Roy, E., Morin, J., Mak, T. W., Tafuri, A., & Boîtard, C. (2010) · European Journal of Immunology · doi:10.1002/eji.201040416 · Cited by 49
Slovak, M. L., Bedell, V., Hsu, Y., Estrine, D. B., Nowak, N. J., Delioukina, M. L., Weiss, L. M., Smith, D. D., & Forman, S. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1071 · Cited by 49
Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis
Chakrabarti, R., Kapse, B., & Mukherjee, G. (2019) · Cancer Reports · doi:10.1002/cnr2.1160 · Cited by 53
Marin, V., Kakuda, H., Dander, E., Imai, C., Campana, D., Biondi, A., & D’Amico, G. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.05.018 · Cited by 52
Opposing Effects of ICOS on Graft-versus-Host Disease Mediated by CD4 and CD8 T Cells
Yu, X., Liang, Y., Nurieva, R., Guo, F., Anasetti, C., & Dong, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7394 · Cited by 50
Regulation of immune and autoimmune responses by ICOS–B7h interaction
Nurieva, R. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.02.010 · Cited by 49
Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
Philips, E. A., Liu, J., Kvalvaag, A. S., Mørch, A. M., Tocheva, A. S., Ng, C., Liang, H., Ahearn, I. M., Pan, R., Luo, C. C., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.ade6256 · Cited by 50
“CD28, ICOS, and CTLA-4 are constitutive homodimers as a consequence of a disulfide linkage in their membrane proximal extracellular stalk regions ( 12–14 ).”
BackgroundCTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer
Karabon, L., Pawlak, E., Tomkiewicz, A., Jedynak, A., Passowicz−Muszyńska, E., Zajda, K., Jonkisz, A., Jankowska, R., Krzakowski, M. J., & Frydecka, I. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.05.010 · Cited by 48
“activation [7].”
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors
Brooks, E. D., Schoenhals, J. E., Tang, C. Z., Micevic, G., Gomez, D. R., Chang, J. Y., & Welsh, J. W. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000210 · Cited by 52
“Immune TOR-opathies,” a Novel Disease Entity in Clinical Immunology
Jung, S., Gámez-Díaz, L. Y., Proietti, M., & Grimbacher, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00966 · Cited by 49
Dynamic host immune response in virus-associated cancers
Cao, S., Wylie, K. M., Wyczalkowski, M. A., Karpova, A., Ley, J. C., Sun, S. Q., Mashl, R. J., Liang, W.-W., Wang, X., Johnson, K. J., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0352-3 · Cited by 49
Liberini, V., Laudicella, R., Capozza, M., Huellner, M. W., Burger, I. A., Baldari, S., Terreno, E., & Deandreis, D. (2021) · Molecules · doi:10.3390/molecules26082201 · Cited by 49
“The inducible T-cell costimulatory receptor (ICOS), mainly expressed on activated cytotoxic T cells, memory T cells and regulatory T cells, seem more specific than [18F]FDG and [18F]AraG [111].”
BackgroundPDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders
James, E. S., Harney, S. M. J., Wordsworth, B. P., Cookson, W., Davis, S. J., & Moffatt, M. F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364223 · Cited by 49
Tan, A. H., Wong, S. C., & Lam, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604081200 · Cited by 48
Shilling, R. A., Pinto, J. M., Decker, D. C., Schneider, D., Bandukwala, H. S., Schneider, J. R., Camoretti-Mercado, B., Ober, C., & Sperling, A. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2061 · Cited by 50
Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
Negron, A., Stüve, O., & Forsthuber, T. G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.607766 · Cited by 47
“Importantly, and in contrast to CD28 and CTLA4, ICOS expression is thought to be restricted to TFH cells and antigen-experienced CD4 + memory T cells and is upregulated during reactivation (172, 182).”
BackgroundVerschraegen, C. F. (2012) · Cancer Management and Research · doi:10.2147/cmar.s15551 · Cited by 49
“23 An increase in the frequency of CD4 + ICOS-high cells is seen in patients treated with ipilimumab, compared to untreated melanoma patients or healthy volunteers.”
Sherkat, R., Yazdani, R., Ganjalıkhani-Hakemi, M., Homayouni, V., & Farahani, R. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.124627 · Cited by 50
Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS
Zhang, Q., Wang, H., Kantekure, K., Paterson, J. C., Liu, X., Schaffer, A., Paulos, C. M., Milone, M. C., Ødum, N., Turner, S. D., et al. (2011) · Blood · doi:10.1182/blood-2011-01-332916 · Cited by 50
Samuelson, E., Laird, R. M., Papillion, A. M., Tatum, A. H., Princiotta, M. F., & Hayes, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092054 · Cited by 50
Signaling Pathways in T Follicular Helper Cells
Rolf, J., Fairfax, K. A., & Turner, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000202 · Cited by 51
Avdeeva, A. S., Rubtsov, Y. P., Dyikanov, D. T., Попкова, Т. В., & Nasonov, E. L. (2020) · Biochimie · doi:10.1016/j.biochi.2020.03.014 · Cited by 225
Hori, J., Kunishige, T., & Nakano, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113962 · Cited by 47
“Inducible co-stimulator (ICOS) is a third member of CD28/CTLA4 family of molecules [54], and it is expressed on activated T cells and resting memory T cells [54–56].”
BackgroundMonteiro, C., Kasahara, T. M., Sacramento, P. M., Dias, A., Leite, S., Silva, V. G., Gupta, S., Agrawal, A., & Bento, C. A. M. (2020) · European Journal of Immunology · doi:10.1002/eji.202048658 · Cited by 53
TH1/TH2-mediated colitis induced by adoptive transfer of CD4+CD45RBhigh T lymphocytes into nude mice
Kanai∥, T., Kawamura, T., Dohi, T., Makita, S., Nemoto, Y., Totsuka, T., & Watanabe, M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000197237.21387.ml · Cited by 47
Nikolova, M. H., Tawab, A., Marie‐Cardine, A., Bagot, M., Boumsell, L., & Bensussan, A. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.doc.x · Cited by 47
Grimbacher, B., Warnatz, K., & Peter, H. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200312000-00001 · Cited by 47
ICOS costimulates invariant NKT cell activation
Kaneda, H., Takeda, K., Ota, T., Kaduka, Y., Akiba, H., Ikarashi, Y., Wakasugi, H., Kronenberg, M., Kinoshita, K., Yagita∥, H., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.004 · Cited by 47
Stimulatory Effects of B7-Related Protein-1 on Cellular and Humoral Immune Responses in Mice
Guo, J., Stolina, M., BREADY, J. V., Yin, S., Horan, T., Yoshinaga, S. K., & Senaldi, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5578 · Cited by 47
Immune mechanisms of childhood asthma
Donovan, C., & Finn, P. W. (1999) · Thorax · doi:10.1136/thx.54.10.938 · Cited by 53
“Additional co-stimulatory molecules include ICOS and CD40/CD40 ligand (CD40L). ICOS is structurally homologous to CD28 but is upregulated after T cell activation.”
BackgroundImmunotherapy in head and neck squamous cell carcinoma: An updated review
Parmar, K., Mohamed, A., Vaish, E., Thawani, R., Cetnar, J. P., & Thein, K. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100649 · Cited by 47
Common Variable Immunodeficiency: Etiological and Treatment Issues
Deane, S., Selmi, C. F., Naguwa, S. M., Teuber, S. S., & Gershwin, M. E. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000226232 · Cited by 46
Immune checkpoint combinations from mouse to man
Ai, M., & Curran, M. A. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1650-8 · Cited by 47
Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases
Solaymani-Mohammadi, S., Eckmann, L., & Singer, S. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00401 · Cited by 49
Intestinal single-cell atlas reveals novel lymphocytes in pigs with similarities to human cells
Wiarda, J. E., Trachsel, J., Sivasankaran, S. K., Tuggle, C. K., & Loving, C. L. (2022) · Life Science Alliance · doi:10.26508/lsa.202201442 · Cited by 46
“…elevated expression of genes associated with CD4 αβ T cell activation (e.g., ICOS , CTLA4 , and CD40LG ; Jaiswal et al, 1996; Linsley & Golstein, 1996; Hutloff et al, 1999; Miragaia et al, 2019; Cano-Gamez et al, 2020), which were also elevated in follicular CD4 αβ T cells (Fig 2B and Table…”
Molecules involved in chemical defence of the chicken egg
Réhault‐Godbert, S., Hervé‐Grépinet, V., Gautron, J., Cabau, C., Nys, Y. Y., & Hincke, M. T. (2011) · Elsevier eBooks · doi:10.1533/9780857093912.2.183 · Cited by 49
Leymarie, O., Jouvion, G., Hervé, P., Chevalier, C., Lorin, V., Lecardonnel, J., da Costa, B. R., Delmas, B., Escriou, N., & Goffic, R. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057894 · Cited by 46
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice
Li, J., Semple, K. M., Suh, W., Liu, C., Chen, F., Blazar, B. R., & Yu, X. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.01.018 · Cited by 49
“Inducible costimulator (ICOS), the third member of the CD28 family [11], is expressed on T cell surface after activation and plays unique roles in T cell activation and”
BackgroundCD28/CTLA‐4–CD80/CD86 and ICOS–B7RP‐1 costimulatory pathway in bronchial asthma
Chen, Y. ‐., & Shi, H. (2005) · Allergy · doi:10.1111/j.1398-9995.2006.01008.x · Cited by 46
Yuan, J. D., Page, D. B., Ku, G. Y., Li, Y., Mu, Z., Ariyan, C. E., Gallardo, H. F., Roman, R.-A., Heine, A. I., Terzulli, S. L., et al. (2010) · PubMed · Cited by 50
A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets
Watanabe, M., Hara, Y., Tanabe, K., Toma, H., & Abe, R. (2005) · International Immunology · doi:10.1093/intimm/dxh206 · Cited by 46
B cells alter the phenotype and function of follicular‐homing CXCR5+ T cells
Ebert, L. M., Horn, M. P., Lang, A. B., & Moser, B. (2004) · European Journal of Immunology · doi:10.1002/eji.200425478 · Cited by 52
Autoantibody Responses and Pathology Regulated by B7-1 and B7-2 Costimulation in MRL/ lpr Lupus
Liang, B., Kashgarian, M. J., Sharpe, A. H., & Mamula, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3436 · Cited by 46
Labib, D., Wang, Z., Prakash, P., Zimmer, M., Smith, M. D., Frazel, P. W., Barbar, L., Sapar, M. L., Calabresi, P. A., Peng, J., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.870085 · Cited by 42
B7h Triggering Inhibits the Migration of Tumor Cell Lines
Dianzani, C., Minelli, R., Gigliotti, C. L., Occhipinti, S., Giovarelli, M., Conti, L., Boggio, E. M., Shivakumar, Y., Baldanzi, G., Malacarne, V., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300587 · Cited by 46
BTNL8, a butyrophilin-like molecule that costimulates the primary immune response
Chapoval, A. I., Smithson, G. M., Brunick, L., Mesri, M., Boldog, F. L., Andrew, D. P., Khramtsov, N. V., Feshchenko, E. A., Starling, G. C., & Mézeš, P. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.08.003 · Cited by 48
Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition
Friedman, C. F., & Postow, M. A. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0509-x · Cited by 46
Preite, S., Huang, B., Cannons, J. L., McGavern, D. B., & Schwartzberg, P. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03079 · Cited by 47
“ICOS is upregulated on activated T cells shortly after TCR stimulation and interacts with ICOS-ligand (ICOS-L) on antigen presenting cells including DCs and B cells (43).”
BackgroundDifferential Control of CD28-Regulated In Vivo Immunity by the E3 Ligase Cbl-b
Krawczyk, C. M., Jones, R. G., Atfield, A., Bachmaier, K., Arya, S., Odermatt, B., Ohashi, P. S., & Penninger, J. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1472 · Cited by 49
Lownik, J. C., Luker, A. J., Damle, S., Cooley, L. F., Sayed, R. E., Hutloff, A., Pitzalis, C., Martin, R., Shikh, M. E. E., & Conrad, D. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700833 · Cited by 49
Self-citationAILIM/ICOS: a novel lymphocyte adhesion molecule
Tamatani, T., Tezuka, K., & Hanzawa-Higuchi, N. (2000) · International Immunology · doi:10.1093/intimm/12.1.51 · Cited by 45
Smirnov, S., Mateikovich, P., Samochernykh, K. A., & Shlyakhto, E. V. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1335424 · Cited by 46
Vu, F., Dianzani, U., Ware, C. F., Mak, T. W., & Gommerman, J. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2284 · Cited by 44
Sakthivel, P., Grünewald, J., Eklúnd, A., Bruder, D., & Wahlström, J. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12715 · Cited by 44
CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas
Le, K.-S., Amé-Thomas, P., Tarte, K., Gondois‐Rey, F., Granjeaud, S., Orlanducci, F., Foucher, E. D., Broussais, F., Bouabdallah, R., Fest, T., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017244 · Cited by 50
“Differential expression of ICOS and CXCR5 defines a distinct subset of CD8 T cells in lymphoma tissues ICOS, a costimulatory molecule of the CD28 family, is strongly expressed on activated T cells.(37) High ICOS expression on TFH cells is important for their generation and for their B-cell helper activity following en…”
BackgroundNuttall, S. D., Rousch, M., Irving, R. A., Hufton, S. E., Hoogenboom, H. R., & Hudson, P. J. (1999) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19990801)36:2<217::aid-prot7>3.0.co;2-x · Cited by 44
Akt Is a Neutral Amplifier for Th Cell Differentiation
Arimura, Y., 白木, 文., Kuwahara, S., Kato, H., Dianzani, U., Uchiyama, T., & Yagi, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309063200 · Cited by 44
Mittrücker, H., Kursar, M., Köhler, A. C., Yanagihara, D. L., Yoshinaga, S. K., & Kaufmann, S. H. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5813 · Cited by 44
Further Mapping of the Idd5.1 Locus for Autoimmune Diabetes in NOD Mice
Lamhamedi-Cherradi, S.-E., Boulard, O., González, C., Kassis, N., Damotte, D., Eloy, L., Fluteau, G., Lévi‐Strauss, M., & Garchon, H. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2874 · Cited by 44
Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
Manso, T., Kushwaha, A., Abdollahi, N., Duroux, P., Giudicelli, V., & Κοσσίδα, Σ. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1129323 · Cited by 44
“ICOS co-stimulation promotes, on the one hand, anti-tumor CTL activation which produces inflammatory cytokines (43, 45) and, on the other hand, Treg cells proliferation which enhances tumor activity (46).”
BackgroundInducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation
Gigoux, M., Lovato, A., Leconte, J., Leung, J., Sonenberg, N., & Suh, W. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.01.008 · Cited by 46
A Transendocytosis Perspective on the CD28/CTLA-4 Pathway
Soskic, B., Qureshi, O. S., Hou, T., & Sansom, D. M. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00004-2 · Cited by 45
Introduction to Costimulation and Costimulatory Molecules
Mir, M. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802585-7.00001-7 · Cited by 59
Park, S. J., Lee, S., Lee, C.-G., Park, G. Y., Hong, H., Lee, J.-S., Kim, Y. M., Lee, S. B., Hwang, D., Choi, Y. S., et al. (2017) · Nature Communications · doi:10.1038/ncomms16037 · Cited by 44
Determinants of Resistance to Checkpoint Inhibitors
Tran, L. L., & Theodorescu, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051594 · Cited by 47
“Upon binding to its ligand (ICOSL), ICOS stimulates T-cell proliferation and cytokine production [33].”
BackgroundA review on applications of abatacept in systemic rheumatic diseases
Liu, M., Yu, Y., & Hu, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107612 · Cited by 46
ICOS cooperates with CD28, IL‐2, and IFN‐γ and modulates activation of human naïve CD4+ T cells
Mesturini, R., Nicola, S., Chiocchetti, A., Bernardone, I. S., Castelli, L., Bensi, T., Ferretti, M., Comi, C., Dong, C., Rojo, J. M., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535571 · Cited by 43
The T cell activation molecule H4 and the CD28-like molecule ICOS are identical
Buonfiglio, D., Bragardo, M., Redoglia, V., Vaschetto, R., Bottarel, F., Bonissoni, S., Bensi, T., Mezzatesta, C., Janeway, C. A., & Dianzani, U. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000012)30:12<3463::aid-immu3463>3.0.co;2-5 · Cited by 43
Sharma, N., Fan, X., Atolagbe, O. T., Ge, Z., Dao, K., Sharma, P., & Allison, J. P. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231263 · Cited by 43
“A member of the CD28/CTLA-4 family, the inducible T cell costimulator (ICOS), is a T cell – specific protein shown to enhance the efficacy of immune checkpoint blockade therapy (Fan et al., 2014; Hutloff et al., 1999; Sharpe and Freeman, 2002).”
BackgroundTh17 Down-regulation Is Involved in Reduced Progression of Schistosomiasis Fibrosis in ICOSL KO Mice
Wang, B., Song, L., Wang, Y., Zhu, X.-Q., Gong, W., Zhang, H.-Q., Li, Y., & Xia, C.-M. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003434 · Cited by 45
Ogata, M., Ito, T., Shimamoto, K., Nakanishi, T., Satsutani, N. M., Miyamoto, R., & Nomura, S. (2012) · International Immunology · doi:10.1093/intimm/dxs103 · Cited by 46
ICOS Deficiency Results in Exacerbated IL-17 Mediated Experimental Autoimmune Encephalomyelitis
Galicia, G., Kasran, A., Uyttenhove, C., Swert, K. D., Snick, J. V., & Ceuppens, J. L. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9287-7 · Cited by 42
Azimzadeh, A. M., Pfeiffer, S., Wu, G., der, C. S., Zorn, G. L., Kelishadi, S. S., Özkaynak, E., Kehry, M. R., Atkinson, J. B., Miller, G. G., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000190099.62847.e6 · Cited by 42
T-cell co-stimulatory molecules: their role in allergic immune reactions
Kallinich, T., Beier, K. C., Wahn, U., Stock, P., & Hamelmann, E. H. (2007) · European Respiratory Journal · doi:10.1183/09031936.00094306 · Cited by 47
Self-citationTransmembrane domain-mediated Lck association underlies bystander and costimulatory ICOS signaling
Wan, Z., Shao, X., Ji, X., Dong, L., Wei, J., Xiong, Z., Liu, W., & Qi, H. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0183-z · Cited by 44
Expression of the B7‐related molecule ICOSL by human glioma cells in vitro and in vivo
Schreiner, B., Wischhusen, J., Mitsdoerffer, M., Schneider, D., Bornemann, A., Melms, A., Tolosa, E., Weller, M., & Wiendl, H. (2003) · Glia · doi:10.1002/glia.10291 · Cited by 42
“The following primary antibodies were used: antihuman ICOS and ICOS-PE (F44; Hutloff et al., 1999), anti-human ICOSL, and ICOSL-PE (HIL-131; Khayyamian et al., 2002; all provided by R.A. Kroczek, Berlin, Germany), anti-HLA-A2 (BB7.”
BackgroundMethodArdjomand, N., McAlister, J. C., Rogers, N. J., Tan, P., George, A. J. T., & Larkin, F. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0084 · Cited by 42
Metadata
- Authors
- Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A.
- Affiliations
- Robert Koch Institute (DE)
- Max Delbrück Center (DE)
- Freie Universität Berlin (DE)
- Corresponding author
- Kroczek, Richard A.
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6716
- Pages
- 263-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1661441964
- Cited by
- 1,482
- References
- 30
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 52 · 2023: 41 · 2022: 66 · 2021: 54 · 2020: 60 · 2019: 53 · 2018: 52 · 2017: 32 · 2016: 44 · 2015: 41 · 2014: 35 · 2013: 53 · 2012: 47
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- ICOS, CD28, CTLA-4, T cell costimulation, T cell proliferation, lymphokine secretion, IL-10, B cell help, germinal center, adaptive immune regulation
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antigens, Differentiation, T-Lymphocyte, Cell Communication, Cell Line, Cloning, Molecular, Humans, Lymphocyte Activation, Mice, Inbred BALB C, Molecular Sequence Data, T-Lymphocytes, CD28 Antigens, Germinal Center, Mice, Inducible T-Cell Co-Stimulator Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.